US Stock MarketDetailed Quotes

AUPH Aurinia Pharmaceuticals

Watchlist
  • 5.430
  • -0.130-2.34%
Close Jul 22 16:00 ET
  • 5.430
  • 0.0000.00%
Post 16:20 ET
776.60MMarket Cap-12627P/E (TTM)

Aurinia Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aurinia Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 1, 2024

Revenue(YoY)

54.69M

+31.80%
EPS(YoY)

<0.01

+110.01%
Analyst Rating

Strong Buy

Jun 30, 2024

Aurinia Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 55.214M--
Aug 1, 20242024/Q2-- / 54.690M--
May 2, 20242024/Q150.303M / 47.074M--
Feb 15, 20242023/Q445.095M / 45.156M--
Nov 2, 20232023/Q354.515M / 38.505M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 55.214M--
Aug 1, 20242024/Q2-- / 54.690M--
May 2, 20242024/Q150.303M / 47.074M--
Feb 15, 20242023/Q445.095M / 45.156M--
Nov 2, 20232023/Q354.515M / 38.505M--

Unlock Free Earnings Estimates

Aurinia Pharmaceuticals Earnings Reports

  • Aurinia Pharmaceuticals | 10-Q: Quarterly report

    May 2 06:13 ET

  • Aurinia Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Apr 29 16:22 ET

  • Aurinia Pharmaceuticals | 10-K: Annual report

    Feb 15 06:22 ET

  • Aurinia Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 06:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg